<?xml version="1.0" encoding="UTF-8"?><mods xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" ID="id-00-24007">
    <name type="corporate">
        <namePart>United States Government Publishing Office</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">publisher</roleTerm>
            <roleTerm authority="marcrelator" type="code">pbl</roleTerm>
        </role>
        <role>
            <roleTerm authority="marcrelator" type="text">distributor</roleTerm>
            <roleTerm authority="marcrelator" type="code">dst</roleTerm>
        </role>
    </name>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>National Archives and Records Administration</namePart>
        <namePart>Office of the Federal Register</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">author</roleTerm>
            <roleTerm authority="marcrelator" type="code">aut</roleTerm>
        </role>
        <description>Government Organization</description>
    </name>
    <typeOfResource>text</typeOfResource>
    <genre authority="marcgt">government publication</genre>
    <language>
        <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
    </language>
    <extension>
        <collectionCode>FR</collectionCode>
        <category>Regulatory Information</category>
        <waisDatabaseName>2000_register</waisDatabaseName>
        <branch>executive</branch>
        <dateIngested>2010-09-24</dateIngested>
    </extension>
    <genre authority="marcgt">article</genre>
    <titleInfo>
        <title>Labeling Requirements for Systemic Antibacterial Drug Products Intended for Human Use</title>
        <partName>Proposed Rules</partName>
    </titleInfo>
    <relatedItem type="otherFormat" xlink:href="https://www.govinfo.gov/content/pkg/FR-2000-09-19/html/00-24007.htm">
        <identifier type="FDsys Unique ID">D09002ee1c81ef8dd</identifier>
    </relatedItem>
    <relatedItem type="otherFormat" xlink:href="https://www.govinfo.gov/content/pkg/FR-2000-09-19/pdf/00-24007.pdf">
        <identifier type="FDsys Unique ID">D09002ee1c81ef958</identifier>
    </relatedItem>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>Department of Health and Human Services</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">originator</roleTerm>
            <roleTerm authority="marcrelator" type="code">org</roleTerm>
        </role>
        <description>United States Government Agency or Subagency</description>
    </name>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>Food and Drug Administration</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">originator</roleTerm>
            <roleTerm authority="marcrelator" type="code">org</roleTerm>
        </role>
        <description>United States Government Agency or Subagency</description>
    </name>
    <abstract>The Food and Drug Administration (FDA) is proposing to require that all systemic antibacterial drug products (i.e., antibiotics and their synthetic counterparts) intended for human use contain additional labeling information about the emergence of drug-resistant bacterial strains. The proposal reflects a growing concern in FDA and the medical community that overprescription and inappropriate use of systemic antibacterials has contributed to a dramatic increase in recent years in the prevalence of drug-resistant bacterial infections. The proposal is intended to encourage physicians to prescribe systemic antibacterials more judiciously and only when clinically necessary. The proposal is also intended to encourage physicians to counsel their patients about the proper use of such drugs and the importance of taking them exactly as directed.</abstract>
    <identifier type="FR citation">65 FR 56511</identifier>
    <identifier type="uri">https://www.govinfo.gov/app/details/FR-2000-09-19/00-24007</identifier>
    <identifier type="FR Doc No.">00-24007</identifier>
    <identifier type="former granule identifier">fr19se00-21</identifier>
    <identifier type="Regulation ID Number">RIN 0910-AB78</identifier>
    <identifier type="billing code">4160-01-F</identifier>
    <identifier type="department code">Docket No. 00N-1463</identifier>
    <location>
        <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/FR-2000-09-19/00-24007</url>
        <url access="raw object" displayLabel="HTML rendition">https://www.govinfo.gov/content/pkg/FR-2000-09-19/html/00-24007.htm</url>
        <url access="raw object" displayLabel="PDF rendition">https://www.govinfo.gov/content/pkg/FR-2000-09-19/pdf/00-24007.pdf</url>
    </location>
    <subject>
        <topic>Drugs</topic>
        <topic>Labeling</topic>
        <topic>Reporting and Recordkeeping Requirements</topic>
    </subject>
    <physicalDescription>
        <extent>8 p.</extent>
    </physicalDescription>
    <part type="Proposed Rules">
        <extent unit="pages">
            <start>56511</start>
            <end>56518</end>
        </extent>
    </part>
    <identifier type="preferred citation">65 FR 56511</identifier>
    <relatedItem type="isReferencedBy">
        <titleInfo>
            <title>Code of Federal Regulations</title>
            <partNumber>Title 21 Part 201</partNumber>
        </titleInfo>
        <identifier type="CFR citation">21 CFR Part  201</identifier>
    </relatedItem>
    <relatedItem type="isReferencedBy">
        <titleInfo>
            <title>Regulation Identification Number 0910-AB78</title>
        </titleInfo>
        <identifier type="regulation ID number">RIN 0910-AB78</identifier>
    </relatedItem>
    <extension>
        <searchTitle>Labeling Requirements for Systemic Antibacterial Drug Products Intended for Human Use; Federal Register Vol. 65, Issue </searchTitle>
        <granuleClass>PRORULE</granuleClass>
        <accessId>00-24007</accessId>
        <agency order="1">DEPARTMENT OF HEALTH AND HUMAN SERVICES</agency>
        <agency order="2">Food and Drug Administration</agency>
        <commentDate>2000-12-04</commentDate>
        <departmentDoc>Docket No. 00N-1463</departmentDoc>
        <rin number="0910-AB78"/>
        <billingCode>4160-01-F</billingCode>
        <frDocNumber>00-24007</frDocNumber>
        <action>Proposed rule.</action>
        <summary>The Food and Drug Administration (FDA) is proposing to require that all systemic antibacterial drug products (i.e., antibiotics and their synthetic counterparts) intended for human use contain additional labeling information about the emergence of drug-resistant bacterial strains. The proposal reflects a growing concern in FDA and the medical community that overprescription and inappropriate use of systemic antibacterials has contributed to a dramatic increase in recent years in the prevalence of drug-resistant bacterial infections. The proposal is intended to encourage physicians to prescribe systemic antibacterials more judiciously and only when clinically necessary. The proposal is also intended to encourage physicians to counsel their patients about the proper use of such drugs and the importance of taking them exactly as directed.</summary>
        <dates>Submit written comments by December 4, 2000. See section III of this document for the proposed effective date of a final rule based on this document.</dates>
        <contact>Gary K. Chikami, Center for Drug Evaluation and Research (HFD-520), Food and Drug Administration, 9201 Corporate Blvd., Rockville, MD 20852, 301-827-2120.</contact>
        <cfr title="21">
                                    
            <part number="201"/>
                                    
            <subject>Drugs</subject>
                                    
            <subject>Labeling</subject>
                                    
            <subject>Reporting and Recordkeeping Requirements</subject>
                                
        </cfr>
        <tocSubject1>Human drugs:</tocSubject1>
        <tocDoc>Systemic antibacterial products; labeling requirements, </tocDoc>
        <urlRef>http://www.ahrq.gov/data/hcup/hcupnet.htm</urlRef>
    </extension>
    <relatedItem type="host" ID="P0b002ee1809fcbd9" xlink:href="https://www.govinfo.gov/metadata/pkg/FR-2000-09-19/mods.xml">
        <titleInfo>
            <title>Federal Register</title>
            <partNumber>Vol. 65, no. 182</partNumber>
        </titleInfo>
        <originInfo>
            <publisher>Office of the Federal Register, National Archives and Records Administration</publisher>
            <dateIssued encoding="w3cdtf">2000-09-19</dateIssued>
            <issuance>continuing</issuance>
            <frequency>daily</frequency>
        </originInfo>
        <physicalDescription>
            <note type="source content type">deposited</note>
            <digitalOrigin>born digital</digitalOrigin>
            <extent>323 p.</extent>
        </physicalDescription>
        <tableOfContents xlink:href="https://www.govinfo.gov/app/frtoc/2000-09-19">    
		  Table of Contents: 
		</tableOfContents>
        <classification authority="sudocs">AE 2.7:</classification>
        <classification authority="sudocs">GS 4.107:</classification>
        <classification authority="sudocs">AE 2.106:</classification>
        <classification authority="lcc">KF70.A2</classification>
        <identifier type="uri">https://www.govinfo.gov/app/details/FR-2000-09-19</identifier>
        <identifier type="local">P0b002ee1809fcbd9</identifier>
        <identifier type="issn">0097-6326</identifier>
        <identifier type="issn">0042-1219</identifier>
        <identifier type="issn">0364-1406</identifier>
        <identifier type="stock number">769-004-00000-9</identifier>
        <identifier type="ILS system id">000582072</identifier>
        <identifier type="former identifier">f:fr19se00</identifier>
        <location>
            <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/FR-2000-09-19</url>
            <url displayLabel="PDF rendition" access="raw object">https://www.govinfo.gov/content/pkg/FR-2000-09-19/pdf/FR-2000-09-19.pdf</url>
            <url displayLabel="XML rendition" access="raw object">https://www.govinfo.gov/content/pkg/FR-2000-09-19/xml/FR-2000-09-19.xml</url>
        </location>
        <accessCondition type="GPO scope determination">fdlp</accessCondition>
        <part type="issue">
            <extent unit="pages">
                <start>56457</start>
                <end>56772</end>
            </extent>
        </part>
        <recordInfo>
            <recordContentSource authority="marcorg">DGPO</recordContentSource>
            <recordCreationDate encoding="w3cdtf">2010-09-24</recordCreationDate>
            <recordChangeDate encoding="w3cdtf">2024-06-08</recordChangeDate>
            <recordIdentifier source="DGPO">FR-2000-09-19</recordIdentifier>
            <recordOrigin>machine generated</recordOrigin>
            <languageOfCataloging>
                <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
            </languageOfCataloging>
        </recordInfo>
        <extension>
            <docClass>FR</docClass>
            <accessId>FR-2000-09-19</accessId>
            <volume>65</volume>
            <issue>182</issue>
        </extension>
    </relatedItem>
</mods>
